Overview

Sitosterolemia Metabolism

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Ezetimibe has become the treatment choice for patients with sitosterolemia. Ezetimibe is an inhibitor of cholesterol absorption from the gastrointestinal tract. The purpose of this study is to determine if ezetimibe improves whole body plant sterol and cholesterol homeostasis.
Phase:
N/A
Details
Lead Sponsor:
University of Manitoba
Treatments:
Ezetimibe